logo

For the Inventor, By the Inventor

San Diego, CA, United States of America

Atyr Pharma, Inc.


USPTO Granted Patents = 93

% Expired Patents = 12.9



Trademarks = 1

Forward Citations = 719

Loading Chart...
Loading Chart...

47 inventors (with patents filed for the assignee):

goldMedal Leslie Ann Greene (74 out of 76 patents)

silverMedal John D Mendlein (67 out of 87 patents)

bronzeMedal Kyle P Chiang (66 out of 68 patents)

4.  Jeffry Dean Watkins (66 out of 106 patents)

5.  Fei Hong (61 out of 62 patents)

6.  Wing-Sze Lo (60 out of 62 patents)

7.  Alain Philippe Vasserot (59 out of 98 patents)

8.  Cheryl L Quinn (54 out of 55 patents)

9.  Kristi Helen Piehl (23 out of 24 patents)

10.  Ryan Andrew Adams (14 out of 14 patents)

11.  Zhiwen Xu (12 out of 12 patents)

12.  Chi-Fang Wu (10 out of 10 patents)

13.  Ying Buechler (10 out of 18 patents)

14.  Ching-Fun Lau (8 out of 9 patents)

15.  Jie Zhou (7 out of 9 patents)


Core Competencies:
Aminoacyl tRNA Synthetases
Histidyl-tRNA Synthetase
Anti-NRP2 Antibodies
Therapeutic Compositions
Lung Inflammation
Polypeptides
Diagnostic Compositions
Cell Signaling Activity
Inflammation Modulation
Protein Fragments
Splice Variants
PEGylated Polypeptides

93 patents:

1. 12492392 - HISTIDYL-TRNA SYNTHETASE-FC CONJUGATES AND THERAPEUTICS USING THE SAME (2025-12-09),
2. 12410253 - Compositions comprising anti-NRP2 antibodies (2025-09-09),
3. 12065495 - Compositions and methods comprising anti-NRP2 antibodies (2024-08-20),
4. 11807687 - Therapeutic compositions comprising anti-NRP2 antibodies (2023-11-07),
5. 11767520 - Compositions and methods for treating lung inflammation (2023-09-26),
6. 11505610 - Compositions and methods comprising anti-NRP2 antibodies (2022-11-22),
7. 11078299 - Compositions and methods comprising histidyl-tRNA synthetase splice variants having non-canonical biological activities (2021-08-03),
8. 11072787 - Histidyl-tRNA synthetase-Fc conjugates (2021-07-27),
9. 10941214 - Compositions and methods comprising histidyl-tRNA synthetase splice variants having non-canonical biological activities (2021-03-09),
10. 10711260 - Histidyl-tRNA synthetase-Fc conjugates (2020-07-14),
11. 10669533 - Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of Histidyl-tRNA synthetases (2020-06-02),
12. 10563192 - Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of threonyl-tRNA synthetases (2020-02-18),
13. 10563191 - Innovative discovery of therapeutic, diagnostic, and antibody compositions related protein fragments of tryptophanyl tRNA synthetases (2020-02-18),
14. 10526419 - Compositions and methods comprising histidyl-tRNA synthetase splice variants having non-canonical biological activities (2020-01-07),
15. 10472618 - Histidyl-tRNA synthetase-Fc conjugates (2019-11-12),
aTyr Pharma, Inc. is a biotechnology company focused on developing innovative protein-based therapeutics to treat severe autoimmune diseases and related disorders. Their unique approach involves harnessing the biology of extracellular tRNA synthetases to discover and develop novel therapeutics. With their expertise in protein science and immunology, aTyr Pharma aims to provide potential treatment options for patients with rare and severe autoimmune diseases.
This text is generated by artificial intelligence and may not be accurate.

logo

Company Badge

USPTO Data Jan 1 1976 - Sep 22 2026

Atyr Pharma, Inc.
93 Patents

#67 in San Diego, CA

#941 in California

#4,019 in US

#8,264 in the World

San Diego, CA (US)
San Diego, CA, United States of America

Atyr Pharma, Inc.

Forward Citations = 719

47 inventors:

goldMedal Leslie Ann Greene (74 out of 76 patents)

silverMedal John D Mendlein (67 out of 87 patents)

bronzeMedal Kyle P Chiang (66 out of 68 patents)

4.  Jeffry Dean Watkins (66 out of 106 patents)

5.  Fei Hong (61 out of 62 patents)

Please report any incorrect information to [email protected]
Loading…